In light of "no news" certainly likely to go lower if markets remain choppy just like it did earlier this year, and certainly something folks should be ready for just in case. I wouldn't get caught with my pants down when they announce synthetic bioequivalence or updates on FragileX trial or MS updates however. In those cases we don't know. Stock is up double in a bear market year on what most would consider insignificant news. Bioequivalence or FragileX could come at any time of course.